» Articles » PMID: 35765038

Pelvic U-Net: Multi-label Semantic Segmentation of Pelvic Organs at Risk for Radiation Therapy Anal Cancer Patients Using a Deeply Supervised Shuffle Attention Convolutional Neural Network

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2022 Jun 28
PMID 35765038
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Delineation of organs at risk (OAR) for anal cancer radiation therapy treatment planning is a manual and time-consuming process. Deep learning-based methods can accelerate and partially automate this task. The aim of this study was to develop and evaluate a deep learning model for automated and improved segmentations of OAR in the pelvic region.

Methods: A 3D, deeply supervised U-Net architecture with shuffle attention, referred to as Pelvic U-Net, was trained on 143 computed tomography (CT) volumes, to segment OAR in the pelvic region, such as total bone marrow, rectum, bladder, and bowel structures. Model predictions were evaluated on an independent test dataset (n = 15) using the Dice similarity coefficient (DSC), the 95th percentile of the Hausdorff distance (HD), and the mean surface distance (MSD). In addition, three experienced radiation oncologists rated model predictions on a scale between 1-4 (excellent, good, acceptable, not acceptable). Model performance was also evaluated with respect to segmentation time, by comparing complete manual delineation time against model prediction time without and with manual correction of the predictions. Furthermore, dosimetric implications to treatment plans were evaluated using different dose-volume histogram (DVH) indices.

Results: Without any manual corrections, mean DSC values of 97%, 87% and 94% were found for total bone marrow, rectum, and bladder. Mean DSC values for bowel cavity, all bowel, small bowel, and large bowel were 95%, 91%, 87% and 81%, respectively. Total bone marrow, bladder, and bowel cavity segmentations derived from our model were rated excellent (89%, 93%, 42%), good (9%, 5%, 42%), or acceptable (2%, 2%, 16%) on average. For almost all the evaluated DVH indices, no significant difference between model predictions and manual delineations was found. Delineation time per patient could be reduced from 40 to 12 min, including manual corrections of model predictions, and to 4 min without corrections.

Conclusions: Our Pelvic U-Net led to credible and clinically applicable OAR segmentations and showed improved performance compared to previous studies. Even though manual adjustments were needed for some predicted structures, segmentation time could be reduced by 70% on average. This allows for an accelerated radiation therapy treatment planning workflow for anal cancer patients.

Citing Articles

Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.

Zemplenyi A, Tachkov K, Balkanyi L, Nemeth B, Petyko Z, Petrova G Front Public Health. 2023; 11:1088121.

PMID: 37181704 PMC: 10171457. DOI: 10.3389/fpubh.2023.1088121.


Deep learning-based classification of organs at risk and delineation guideline in pelvic cancer radiation therapy.

Lempart M, Scherman J, Nilsson M, Gustafsson C J Appl Clin Med Phys. 2023; 24(9):e14022.

PMID: 37177830 PMC: 10476996. DOI: 10.1002/acm2.14022.

References
1.
Delpon G, Escande A, Ruef T, Darreon J, Fontaine J, Noblet C . Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer Radiotherapy. Front Oncol. 2016; 6:178. PMC: 4971890. DOI: 10.3389/fonc.2016.00178. View

2.
Fiorino C, Reni M, Bolognesi A, Cattaneo G, Calandrino R . Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol. 1998; 47(3):285-92. DOI: 10.1016/s0167-8140(98)00021-8. View

3.
Zabel W, Conway J, Gladwish A, Skliarenko J, DiDiodato G, Goorts-Matthews L . Clinical Evaluation of Deep Learning and Atlas-Based Auto-Contouring of Bladder and Rectum for Prostate Radiation Therapy. Pract Radiat Oncol. 2020; 11(1):e80-e89. DOI: 10.1016/j.prro.2020.05.013. View

4.
Mell L, Schomas D, Salama J, Devisetty K, Aydogan B, Miller R . Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007; 70(5):1431-7. DOI: 10.1016/j.ijrobp.2007.08.074. View

5.
Lustberg T, Soest J, Gooding M, Peressutti D, Aljabar P, van der Stoep J . Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer. Radiother Oncol. 2017; 126(2):312-317. DOI: 10.1016/j.radonc.2017.11.012. View